We diagnose to cure.

Predicta Biosciences is transforming the patient journey with innovative diagnostic tools to enable better diagnosis, treatment, and monitoring, all from a small blood sample.

The Predicta platform captures multi-omics and immune system patient data to build a one-of-a kind clinical database. Our data is constantly growing to improve treatment across existing and new therapies. Using AI, we identify novel drug targets and immune signatures to one day cure the patients we diagnose.

Vision

Our Mission

Predicta Biosciences is a precision oncology company integrating cutting-edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products.

Our platform utilizes AI and cutting edge multi-omics technology to develop personalized treatment options for patients. We believe in empowering clinicians with the tools and knowledge they need to make informed decisions and provide the best care possible.

Remove painful, invasive tests

Predicta's diagnostic products remove the burden of bone-marrow biopsies, through small blood-based samples, enabling easy diagnosis and monitoring throughout the patient journey.

Diagnostics to Cure

Our diagnostic platform is fueling an enormous database. We mine this data using AI tools to discover novel therapeutic targets.

Diagnostic Solutions

A diagnostic solution for providers and payers to ensure patients are prescribed optimal therapy throughout their journey.

Furthermore, our tests provide clear, actionable data when patients will NOT respond.

Patients First

Our patient centric company culture drives us to design and build products to meet the needs of patients through-out their journey. This includes empowering patients with resources and information about their unique molecular data, treatment options, and monitoring recommendations.